Collection

COVID-19 vaccination programme

Documents relating to the new coronavirus (COVID-19) vaccination programme.

From:
UK Health Security Agency
Published
27 November 2020
Last updated
2210 DecemberJanuary 20212022 — See all updates

Blood clotting, myocarditis and pericarditis, and Guillain-Barré Syndrome (GBS)

See the COVID-19 vaccination and rare side effects for information and guidance on these very rare conditions reported after COVID-19 vaccination.

Coronaviruses are a large family of viruses that cause respiratory infections. These can range from the common cold to more serious diseases.

COVID-19 is caused by a new form of coronavirus known as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). It was first reported in December 2019.

Pregnant women who are inadvertently immunised should be notified to the Vaccine in Pregnancy surveillance programme.

Further information is available on NHS.UK and on GOV.UK

Guidance

Training resources

COVID-19 vaccination training slide set

COVID-19 vaccination e-learning programme

Consent forms and letters

Accessing COVID-19 vaccination without an NHS number

Leaflets, posters and resources

A MMR, MenACWY and COVID-19 vaccines communications toolkit for universities is available to download.

Social media resources promoting COVID-19 vaccination in migrant communities in London and nationally are available to download.

Social media resources promoting COVID-19 vaccination for pregnant women are available to download.

Surveillance

Protocols and patient group directions (PGDs)

The PGDs to support the COVID-19 vaccination programme are available to download:

PGD for COVID-19 Comirnaty® (Pfizer/BioNTech)30micrograms/dose COVID19 mRNA vaccine

PGD for COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech)

PGD for COVID-19 Vaccine AstraZeneca, (ChAdOx1-S [recombinant])

PGD for Spikevax (formerly COVID-19 Vaccine ModernaModerna)

Programme documents

Published 27 November 2020
Last updated 2210 DecemberJanuary 20212022 + show all updates

  1. Added JCVI statement on the adult COVID-19 booster vaccination programme and the Omicron variant.

  2. Added JCVI update on advice for COVID-19 vaccination of children and young people.

  3. Added 'Suspension of the 15-minute wait for vaccination with mRNA vaccine for COVID-19: UK CMOs opinion' and 'COVID-19 vaccination observation period'.

  8. Added COVID-19 vaccinations received overseas.

  9. Added 'COVID-19 vaccination: checklist for parents of children aged 12 to 15 years'.

  10. Added links to social media resources aimed at pregnant women.

  12. Added COVID-19: provision of immunisation sessions for outbreaks in schools.

  14. Updated COVID-19 vaccination training slide set.

  15. Added COVID-19 vaccination: booster dose resources.

  17. Added COVID-19 vaccination: easy-read resources for children and young people.

  18. Added COVID-19 vaccination for people with a weakened immune system.

  20. Added link to the MMR, MenACWY and COVID-19 vaccines communications toolkit for universities.

  21. Added link to Comirnaty® PGD.

  25. Updated COVID-19 vaccination training slide set.

  26. Added COVID-19 vaccination: resources for children and young people and COVID-19 vaccination of children and young people JCVI statements.

  30. Added 'COVID-19 vaccination: guide for employers'.

  31. Updated COVID-19 vaccination training slide set.

  32. Added link to the COVID-19 Vaccine Moderna PGD.

  33. Added 'COVID-19 vaccine surveillance report'.

  34. Added link to updated COVID-19 vaccination training slide set.

  36. Updated COVID-19 vaccination training slide set.

  39. Added 'COVID-19 vaccination: booking an appointment letter' and 'Letter from the Health and Social Care Secretary on COVID-19 vaccination phase 1 advice'.

  41. Added updated COVID-19 vaccination training slide set link, 'PHE monitoring of the effectiveness of COVID-19 vaccination' and 'Letter from the Health and Social Care Secretary on COVID-19 vaccination in people with learning disabilities'.

  44. Added British Sign Language resources.

  46. Added the use of human and animal products in vaccines guide.

  47. Added 'COVID-19 vaccine monitoring reports' to the surveillance section.

  48. Added 'COVID-19: enhanced surveillance of cases in vaccinated individuals'.

  49. Added COVID-19: vaccine surveillance strategy and updated COVID-19 vaccination training slide set.

  50. Added National protocol for COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant]).

  52. Added link to the COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant]) PGD.

  53. Added: Revised COVID-19 vaccination training slide set and Priority groups for COVID-19 vaccination: advice from the JCVI, 30 December 2020.

  55. Training slide set updated.

  58. Added information leaflets, consent forms and link to updated COVID-19 vaccination training slide set.

  59. Added 'COVID-19 vaccination: women of childbearing age, pregnant, planning a pregnancy or breastfeeding'.

  60. Added 'Priority groups for COVID-19 vaccination: advice from the JCVI, 2 December 2020'.

Contents